Literature DB >> 30058082

Overcoming diagnostic and treatment challenges in uveitic glaucoma.

Erin R Sherman1, Malinda Cafiero-Chin2.   

Abstract

Uveitic glaucoma is a range of disorders that results in optic nerve damage from elevated intraocular pressure secondary to intraocular inflammation. As compared to primary open angle glaucoma, uveitic glaucoma is associated with a more aggressive disease course caused by very high intraocular pressure levels that wax and wane. Diagnosis is often based on clinical presentation, disease course, and associated systemic manifestations. Diagnostic imaging plays an important role in both diagnosis and management. While the mechanisms of uveitic glaucoma vary, treatment requires strict control of the inflammation and may involve additional intraocular pressure lowering techniques. Management often dictates an interdisciplinary approach as systemic association and treatment is common. When topical management does not slow the progression of optic nerve damage and vision loss, surgical intervention is required. A significant portion of patients with uveitic glaucoma will eventually require surgical intervention and the appropriate referrals should be made. By nature, success rates of surgical intervention in uveitic glaucoma patients are lower than non-inflammatory causes of elevated intraocular pressure and glaucomatous damage. Chronic inflammation, multiple mechanisms, systemic associations, and unpredictable response to treatment make uveitic glaucoma challenging to manage. This review will discuss the pathophysiology, diagnosis, and management of uveitic glaucoma to provide a guide for eye-care providers.
© 2018 Optometry Australia.

Entities:  

Keywords:  corticosteroids; glaucoma; inflammation; uveitic glaucoma; uveitis

Mesh:

Year:  2018        PMID: 30058082     DOI: 10.1111/cxo.12811

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  4 in total

1.  The Histopathology of Two Eyes Enucleated after Continuous Transscleral and Micropulse Transscleral Cyclophotocoagulation for Refractory Secondary Glaucoma.

Authors:  Imani M Williams; Vamsee K Neerukonda; Anna M Stagner
Journal:  Ocul Oncol Pathol       Date:  2022-01-24

2.  Assessment of Anterior Chamber by Ultrasound Biomicroscopy and Anterior Segment Optical Coherence Tomography in Patients with Inflammatory Glaucoma.

Authors:  Yiyong Qian; Lin Liu; Yuehui Shi; Minli Wang; Min Li; Jun Zou
Journal:  J Int Med Res       Date:  2019-10-08       Impact factor: 1.671

3.  Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling.

Authors:  Adam C Mirando; Raquel Lima E Silva; Zenny Chu; Peter A Campochiaro; Niranjan B Pandey; Aleksander S Popel
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

4.  Surgical Approach and Outcomes of Uveitic Glaucoma in a Tertiary Hospital.

Authors:  Nestor Ventura-Abreu; Joana Mendes-Pereira; Marta Pazos; Ma Jesús Muniesa-Royo; Andrea Gonzalez-Ventosa; Barbara Romero-Nuñez; Elena Milla
Journal:  J Curr Glaucoma Pract       Date:  2021 May-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.